We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.54 | 2.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/4/2021 18:48 | iM slurping homemadeBrocolli juice burp monyM isThe biggest p&dWhoe | andymunchkin | |
10/4/2021 18:28 | last pump&dump byMoneymunch from £12 to 12pence wtfffffffff??? YeeeeehaaaaaawwwwwW | andymunchkin | |
10/4/2021 15:51 | I'm hoping this statement from Prof Chalmers is a reference to SFX-01's potential to treat Covid-19, ARDS, Pneumonia and other common Respiratory diseases/infections and a hint that he already has the eagerly awaited preliminary efficacy assessment data from SFX-01's Covid/ARDS patient trial...news next week??? Gla :-) "There has been incredible innovation during the Covid-19 pandemic, with acceleration of digital technologies, better ways of delivering healthcare and developments in vaccines and treatments that could be applied to many common diseases." | moneymunch | |
09/4/2021 20:48 | Lol...don't take wet mate, there's been 30 recorded cases and 7 recorded deaths in the UK of blood clots that have looked unusual because of low platelet counts, yet 18m plus people have had the AZ jab, and they reckon those with Covid stand a 1 in 6 chance of getting a blood clot, and hundreds if not thousands are dying in Europe..4 thousand plus died in Brazil yesterday, yet the UK numbers for deaths, infections and hospitalisation are at an all time low, yet the majority of Europe are in or are planning a third lockdown...almost 40% UK citizens vaccinated, and only 12% of the whole of Europe...Boris deserves a medal....the Brits will be going on holiday in July and August because of low numbers of cases, but they certainly won't going to mainland Europe unless things drastically change...which appears unlikely. Gl ;') Ps can't wait for my second AZ jab....;-) | moneymunch | |
09/4/2021 20:44 | anyone here into Crypto ? Shard coin about to be listed on ETH and BSC in the next 2 weeks.. will be a quick few hundred % profit | dlg3 | |
09/4/2021 20:40 | The United Kingdom decided on Wednesday to limit the use of the AstraZeneca vaccine to people under the age of 30. Makes it harder to explain why a 30 year old healthy person dies of blood clots, so that is the reason for the age limit put at 30, a 34 year old nurse in Portugal died after having AZ jab,perfectly healthy beforehand.... that is the trouble when there is a race on, things get overlooked and the UK gov. may come to regret rushing ahead.. | dlg3 | |
09/4/2021 20:28 | money come back in a month,s time, the third wave will be hitting the UK, figures still higher than July and August 2020..the correct figures for blood clots not fully documented, I know of six people that have died of blood clots after having AZ jab, the uk gov. will be pooing their pants after going ahead with no responsibility falling back on to AZ...and the Tax payer having to foot the bill.... | dlg3 | |
09/4/2021 19:30 | Meanwhile here, the pubs are opening up on Monday. Cheers :-) | moneymunch | |
09/4/2021 19:26 | Lol, I've had my AZ jab and proud to have it, Europe and the majority of the rest of the World appears to be in a right mess, the pandemic is surging out of control in many of the countries that have been anti-AZ...Gl :-) | moneymunch | |
09/4/2021 18:49 | Quick someone give Johnson his second shot of the Astra jab, or will he not be taking it now ??? | dlg3 | |
09/4/2021 18:48 | yes Prince Philipp had the astra jab and ended up in hospital 3 weeks later with his ticker, coincidence ???? there is a reason that astra wanted not to be held responsible if something went wrong !!!! Now the Government (or should I say the Tax payers) are picking up Astra claims tab..going to cost a fortune, no wonder the UK government are playing down the blood clot problem..... Press release Government to add COVID-19 to Vaccine Damage Payments Scheme | dlg3 | |
09/4/2021 17:51 | why would you want a blood clot, Azn have a jab if that's any good .. | dutch123 | |
09/4/2021 15:32 | Has EVG got anything for blood clots? | alancapone | |
09/4/2021 15:19 | Multiple newsflow expected from Huw across the pipeline, including Prof Chalmers preliminary efficacy assessment for Covid/ARDS, where positive data will be a complete game changer for all invested, and news on the IND could also be close which could be very well received. Momentum and excitement building in anticipation. Gla ;-) SIGNIFICANT LANDMARK An ambition (and a potential significant landmark/catalyst for the business) will be the filing of an investigational new drug application (IND) in the US for SFX-01, though medical indication for the drug hasn’t been decided. | moneymunch | |
08/4/2021 22:40 | nearly £500,000 trade, looks like someone knows something.. | dlg3 | |
08/4/2021 22:38 | Price has been held back to fill those chunky trades, this will rocket once they let it go.... | dlg3 | |
08/4/2021 19:53 | Wow, a chunky trade indeed...news coming soon I reckon. :-) | moneymunch | |
08/4/2021 19:14 | Even chunkier 5,497,762 trade just shown. Fingers crossed this is the end of the anchor. | on target | |
08/4/2021 14:21 | Some nice chunky buys hoovering UP the cheap shares, as usual....back to double figures soon enough imho in anticipation of multiple material newsflow expected from Huw this Q2....Gla ;-) | moneymunch | |
07/4/2021 21:58 | Maybe an opportune time to report any progress on any oncology target. Gla :-) AACR ANNUAL MEETING 2021Virtual MeetingWeek 1: April 10-15; Week 2: May 17-21 The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world. | moneymunch | |
07/4/2021 21:18 | James Chalmers United Kingdom James Chalmers is Professor of Respiratory Medicine at the University of Dundee and a consultant physician. Graduating from the University of Glasgow’s School of Medicine, he has since gone on to obtain a doctorate from the University of Edinburgh, and is now a member of Edinburgh’s Royal College of Physicians. He has published more than 200 peer reviewed papers, chairs the European Bronchiectasis Registry, and serves regularly as a reviewer for each of the major respiratory medicine journals (American Journal of Respiratory and Critical Care Medicine, Thorax, European Respiratory Journal, Chest, Respiratory Medicine). His research operates at both translating basic discoveries into therapies, and translating therapies into clinical practice, and has deliberately focussed on areas of perceived need in respiratory medicine, with high morbidity and mortality but limited investment in research. ........ Background The DRAGON project is coordinated by the University of Maastricht with Radiomics as the Project Lead, and partners comprised of high-tech small and medium-sized enterprises (SMEs), academic research institutes, biotechnology and pharmacological partners, and ELF and ERS. Funded by the Innovative Medicines Initiative (IMI), it will use AI and machine learning to deliver a patient-centred decision support system that will enable stakeholders to participate in the development of rapid precise diagnosis and prognosis. “The application of digital imaging together with clinical data to inform clinical decisions through artificial intelligence is very exciting. The DRAGON project offers to do this as part of our response to the pandemic.”&nbs | moneymunch | |
07/4/2021 21:06 | All welcome to the other Evgen thread, including you nobby, apart from those intent on destruction and mindless distraction...On and UP!!! :-) | moneymunch | |
07/4/2021 20:50 | Prof Chalmers, Lead investigator for SFX-01 Covid/ARDS patient trials, is on the organisation committee for the following event, and so every chance that he could be reporting good news on SFX-01's efficacy for Covid/Ards 29th April 2021.Gla ;-) COVID-19: State of the art – DRAGON IMI project 29 April, 2021 Online A full-day virtual event dedicated to COVID-19, where top level faculty will share the latest advances, data and best practices relating to SARS-CoV-2 and COVID-19. “This event brings together world-leaders tackling COVD-19 and how different digital approaches to big data will help us to defeat the pandemic” – Professor Christopher Brightling, event co-chair. | moneymunch | |
07/4/2021 19:55 | Covid-19 pandemic seems to be surging out of control around the rest of the World, and so the upside here could be "breathtaking" if Prof Chalmers confirms SFX-01's efficacy....there are very few ( if any ) clear cut effective treatments that come anywhere near to the therapeutic benefits documented by John Hopkins University suggesting Sulforaphane as a promising treatment for Covid-19 and many variants as well as ARDS etc, and so can you imagine if the potent synthetic form of Sulforaphane, SFX-01, has a similar confirmed effect???!!!!...it seems like the risk reward is firmly tipped towards our favour.:-) | moneymunch |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions